Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY: LLY )

324.71 +0.48 (+0.15%)
Official Closing Price Updated: 7:00 PM EDT, Jul 1, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Eli Lilly

< Previous 1 2
...
12 13 14 15 16 17 18 19 Next >
FDA Approves Eli Lilly's Jardiance For Heart Failure
The FDA approves Eli Lilly And Co (NYSE: LLY) - Boehringer Ingelheim's Jardiance (empagliflozin) 10 mg for heart failure. The approval comes to... 
Via Benzinga
Exposures Product Safety
The Daily Biotech Pulse: AzurRx Jumps On Data, Agios' Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 17) AbbVie Inc. (NYSE: ABBV)... 
Via Benzinga
Exposures Product Safety
Stocks That Hit 52-Week Highs On Tuesday
Before 10 a.m. ET on Tuesday, 55 companies set new 52-week highs. Points of Interest: Apple (NASDAQ:AAPL) was the largest company by market cap to set a new 52-week... 
Via Benzinga
The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 16) Bio-Rad Laboratories, Inc... 
Via Benzinga
Unusual Options Activity Insight: Eli Lilly
On Wednesday, shares of Eli Lilly (NYSE:LLY) saw unusual opt... 
Via Benzinga
Analyst Ratings For Eli Lilly
Analysts have provided the following ratings for Eli Lilly (NYSE:LLY) within ... 
Via Benzinga
Eli Lilly Stock Soars To 96 Composite Rating
Eli Lilly saw its IBD SmartSelect Composite Rating rise to 96 Monday, up from 94 the day before. 
Via Investor's Business Daily
FDA Clears Use Of Eli Lilly's Insulin With Insulet's Infusion Pumps
The 
Via Benzinga
Exposures Product Safety
Innovent's Sintilimab/Chemo Regime Shows Overall Survival Benefit In Gastric Cancer
Innovent Biologics Inc (OTC: IVBIY) has announced topline results from Phase 3 ORIENT-16 study evaluating sintilimab, meeting the primary endpoint of overall... 
Via Benzinga
Lilly's Lebrikizumab Shows Clinical Benefit In Late-Stage Atopic Eczema Trials
Eli Lilly And Co's (NYSE: LLY) lebrikizumab ADvocate 1 and ADvocate 2 Phase 3 clinical trials met primary and all key secondary endpoints at Week 16. ... 
Via Benzinga
Why AbCellera Biologics Stock Was Up More Than 17% on Friday
The biopharma company's second quarter was better than expected. The future looks pretty bright, too. 
Via The Motley Fool
The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 4) Absci, CORP (NASDAQ: ABSI) (... 
Via Benzinga
Analyzing Eli Lilly's Unusual Options Activity
On Wednesday, shares of Eli Lilly (NYSE:LLY) saw unusual opti... 
Via Benzinga
Vaccine Stocks Fly On Booster Shot OK, But Their Run Could Be Short-Lived
Vaccine stocks popped Friday after the FDA authorized a third dose of their Covid shots from some immunocompromised people. 
Via Investor's Business Daily
Exposures Product Safety
5 Stocks Insiders Are Selling
When insiders sell shares, it indicates their concern in the company’s prospects or that they view the stock as being overpriced. Either way, this signals an opportunity to... 
Via Benzinga
3 Pharma Stocks to Buy in August
These stocks offer solid growth opportunities. 
Via The Motley Fool
5 Stocks Insiders Are Selling
When insiders sell shares, it indicates their concern in the company’s prospects or that they view the stock as being overpriced. Either way, this signals an opportunity to... 
Via Benzinga
Innovent - Eli Lilly's Sintilimab Combo Shows Sustained Survival Benefit In Lung Cancer Patients
Innovent Biologics Inc (OTC: IVBIY) and Eli Lilly And Co (NYSE: LLY) have announced new and updated data from the ORIENT-11 Phase 3 study of sintilimab... 
Via Benzinga
The Daily Biotech Pulse: Arcturus Soars On COVID-19 Vaccine Updates, Merck's Keytruda On Track For More Label Expansions, Eliem Debuts
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 9) Adagio Therapeutics, Inc. (... 
Via Benzinga
Exposures COVID-19
Stock Market Rally Hits Highs Amid Strong Earnings, Jobs; Square, GM, Etsy Among Key Movers
The Dow, S&P 500 and Nasdaq amid heavy earnings and a hot jobs report. Square, GM and Etsy were notable movers. 
Via Investor's Business Daily
Topics Stocks
Exposures Fossil Fuels US Equities
Benzinga's Top Ratings Upgrades, Downgrades For August 5, 2021
Upgrades Stephens & Co. upgraded the previous rating for Roku Inc (NASDAQ: 
Via Benzinga
Moderna’s (MRNA) Massive Market Cap
As could have been expected in the midst of a global pandemic, one of the most rapidly growing companies has been vaccine producer Moderna. 
Via Talk Markets
Eli Lilly, A Five-Year Analysis: How Important Is Re-Investing Dividends?
Compounding Returns In a world obsessed with price movements of stocks, it's easy to lose sight of what those prices represent -- the value of holding a company's future profit... 
Via Benzinga
If You Invested $24,370 in This Top Stock 5 Years Ago, You'd Be Making $1,000 in Dividends This Year
Plus your investment would be worth nearly three times its original value. 
Via The Motley Fool
Eli Lilly and Company (LLY) Q2 2021 Earnings Call Transcript
LLY earnings call for the period ending June 30, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
4 Top Stock Trades for Wednesday: Ethereum, Bitcoin, LLY, HOOD
Ethereum, Bitcoin, Eli Lilly and Robinhood were our top stock trades for Wednesday. Now, let's look at the charts after some nice movement. 
Via InvestorPlace
The Daily Biotech Pulse: Pfizer's Positive Readout, NRx Strikes R&D Collaboration With Mannkind, Cerus & Invitae Jump On Earnings
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 3) Absci, CORP (NASDAQ: ABSI) (... 
Via Benzinga
Another Big Earnings Week Ahead
After a monumental week of Big Tech earnings, we're in for more than a quarter of S&P 500 companies' reports, including those from Alibaba (NYSE: BABA), General Motors... 
Via Benzinga
Topics Stocks
Exposures US Equities
Lilly Stock Slips On Mixed Bag Q2 Earnings, Cuts FY21 Sales Outlook For COVID-19 Therapies
Eli Lilly And Co posted Q2 sales of $6.74 billion, beating the consensus of $6.65 billion and an increase of 23% Y/Y, 
Via Talk Markets
Exposures COVID-19
The Daily Biotech Pulse: Sanofi Buys Translate Bio In $3.2B Deal, Lilly's Q2 Earnings Disappoint, Bausch To Spin Off Medical Aesthetics Business
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 2) Absci, CORP (NASDAQ: ABSI) (... 
Via Benzinga
< Previous 1 2
...
12 13 14 15 16 17 18 19 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.